reference/1926519

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1926519

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	179
issn	0002-9637 1476-1645
issueIdentifier	1
pageRange	164-179
publicationName	The American Journal of Tropical Medicine and Hygiene
startingPage	164
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e3c18600b59b2612497bf6b95256a2d6
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_601f5159c00f251aa0fcc2c304460d88 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_df63668457cd1115810af31334c37b0c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c8d18da2f33c079156e7833860f9e062
bibliographicCitation	Gilbert PB, Huang Y, Juraska M, Moodie Z, Fong Y, Luedtke A, Zhuang Y, Shao J, Carpp LN, Jackson N, Chambonneau L, Bouckenooghe A, Zambrano B, Frago C, Pallardy S, Noriega F. Bridging Efficacy of a Tetravalent Dengue Vaccine from Children/Adolescents to Adults in Highly Endemic Countries Based on Neutralizing Antibody Response. Am J Trop Med Hyg. 2019 Jul;101(1):164–79. PMID: 31115304; PMCID: PMC6609170.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8652a8f567ec70ad09114869a13f296a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9420-7285 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0d7ef0d7c7ed597e6623f4b5678163e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27be81ab215a999e6cad38d4d78b8127 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93be200d68f1bc4785f9ecf31373bee1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db996a40d8da5759fd22384b933ed8bf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79f44ee65c67f163da42e903f5b1b6bd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d9f96d184f5539b9a8510cd3fe1b273 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2738fcf7503e92f2db61b7ea621871d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4f0cf4c5f4313c6849b1987a4fceb07 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5fa106ef2a4526a4f188457cd9878cbc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c341988e8599008a45820ebade28cd23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0dd32d0f173aa6e94193dae6169d4c5a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7a855b854b0f915caa9358391365027 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_14a673448359b8574ac72fceb7460d1c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4aead4c725fc2d86be583aa7c276a94d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84da70fbe286cd7e1ca19379bc2db580
date	2019-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC6609170 https://doi.org/10.4269/ajtmh.18-0534 https://pubmed.ncbi.nlm.nih.gov/31115304
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/473 https://portal.issn.org/resource/ISSN/0002-9637 https://portal.issn.org/resource/ISSN/1476-1645
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Bridging Efficacy of a Tetravalent Dengue Vaccine from Children/Adolescents to Adults in Highly Endemic Countries Based on Neutralizing Antibody Response
discusses	http://id.nlm.nih.gov/mesh/M0491092 http://id.nlm.nih.gov/mesh/M0001361 http://id.nlm.nih.gov/mesh/M0534745
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D003715Q000517 http://id.nlm.nih.gov/mesh/D057134Q000097 http://id.nlm.nih.gov/mesh/D000914Q000097 http://id.nlm.nih.gov/mesh/D019353Q000517 http://id.nlm.nih.gov/mesh/D003716Q000276 http://id.nlm.nih.gov/mesh/D053059Q000592
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D053059Q000276 http://id.nlm.nih.gov/mesh/D065288 http://id.nlm.nih.gov/mesh/D003716Q000145 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D010948 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D002648

Total number of triples: 61.